Skip to main content
. 2021 Dec 9;10(12):1599. doi: 10.3390/pathogens10121599

Table 4.

Peptide inhibitors of SARS-CoV-2 fusion *.

Peptide Target Experimental System Reference
EK1 S-protein NHR (HR1) Cell–cell fusion; pseudo-virus infection [49]
EK1C4 S-protein NHR (HR1) Cell–cell fusion; pseudo-virus infection [49]
IBP02 S-protein NHR (HR1) Cell–cell fusion; pseudo-virus infection [51]
SARS-CoV-2 HRC lipopeptide S-protein NHR (HR1) Cell–cell fusion; virus infection [50]

* Abbreviations: NHR (HR1), N-terminal heptad repeat, also termed HR1.